Affiliations 

  • 1 Department of Dermatology, Jose R. Reyes Memorial Center, Manila, the Philippines
  • 2 The KL Skin Center, Kuala Lumpur, Malaysia
  • 3 National Skin Center, Singapore
  • 4 Delhi Dermatology Group, Delhi, India
  • 5 Department of Dermatology, Toranomon Hospital, Tokyo, Japan
  • 6 Chulalongkorn University Hospital, Bangkok, Thailand
  • 7 Central Sydney Dermatology, Sydney, New South Wales, Australia
  • 8 Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea
  • 9 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
  • 10 Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
J Dermatol, 2016 Jul;43(7):826-8.
PMID: 26813513 DOI: 10.1111/1346-8138.13263

Abstract

In patients with darker skin types (Fitzpatrick phototypes III-VI), acne is often accompanied by post-inflammatory hyperpigmentation (PIH). Further, acne-related pigmentation can pose a greater concern for the patient than the acne lesions. There has been little formal study of this acne-related PIH. Recently, the Asian Acne Board - an international group of dermatologists with interest in acne research - made a preliminary evaluation of the frequency and characteristics of PIH in seven Asian countries. A total of 324 sequential acne subjects were evaluated for the presence of PIH. The majority (80.2%) of subjects had mild to moderate acne and there were more females than males (63.0% vs 37.0%). In this population of patients consulting a dermatologist for acne, 58.2% (188/324) had PIH. The results also showed that pigmentation problems are often long lasting: at least 1 year for more than half of subjects and 5 years or longer in 22.3%. In accordance with our clinical experience, patients reported that PIH is quite bothersome, often as bothersome or more so than the acne itself and sometimes more problematic. Excoriation was commonly reported by patients, and may represent a modifiable risk factor that could potentially be improved by patient education.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.